Intercept submits applications for marketing approval of obeticholic acid for the treatment of PBC
30 June 2015 | By Victoria White
Intercept Pharmaceuticals has achieved two important regulatory milestones for obeticholic acid in primary biliary cirrhosis (PBC)...